Prosecutors are examining whether the companies violated the federal Controlled Substances Act, which requires companies to report orders of controlled substances that are unusually large or frequent, or that substantially deviate from norm. The probe is in its early stages.

from Kaiser Health News https://ift.tt/37IgBAr

Related Posts:

0 comments:

Post a Comment

Popular Posts